An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia

被引:18
|
作者
Hopkins, PM
Ellis, FR
Halsall, PJ
Stewart, AD
机构
[1] Malignant Hyperthermia Invest. Unit, St. James's University Hospital, Leeds
[2] Malignant Hyperthermia Invest. Unit, St. James's University Hospital
来源
ANESTHESIA AND ANALGESIA | 1997年 / 84卷 / 03期
关键词
D O I
10.1097/00000539-199703000-00034
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
An objective estimate of the likelihood of correct designation of malignant hyperthermia (MH) susceptibility from in vitro contracture test (IVCT) results is essential if genetic linkage studies of MPI are robe more informative. The aim of this study was to generate and test statistical models that could be used to predict the probability of susceptibility of an individual to MH from the results of their IVCTs. Logistic regression of the IVCT results of an index group of 50 patients (age range 9-73 years; MH susceptible [MHS], n = 13; MH normal [MHN], n = 32; MH equivocal [MHE], n = 5) who were either at low risk of MH or were proband cases were used to generate models to predict probability of MH susceptibility. Models incorporated data from individual contracture tests or from combinations of tests (static halothane, dynamic halothane, caffeine, ryanodine) performed according to the protocols of the European Malignant Hyperthermia Group. Of the individual contracture tests, the ryanodine test was most closely correlated with MH status. Discriminatory ability of the models was assessed using receiver operating characteristic (ROC) curves. Inclusion of predictor variables from the ryanodine, caffeine, and dynamic halothane tests improved upon the discriminatory ability of the models incorporating variables from individual tests and was considered to be the best model, The reproducibility of this model was confirmed using an ROC curve constructed using data from 47 patients (age range 10-62 years; MHS, n = 15; MHN, n = 28; MHE, n = 4) who were classified in a way similar to the index soup. A further group of 153 patients (age range 9-74 years; MHS, n = 44; MHN, n = 92; MHE, n = 17) who were consecutively tested relatives of susceptible individuals was used to assess the generalizability of the best model. The model met the criteria for a useful discriminatory model with this group of patients, 125 of whom (including 9 MHE patients) could be designated as positive or negative for MH with a likelihood of more than 95%. The logistic regression models provide objective likelihoods for the MPI phenotype that could be usefully incorporated into genetic linkage studies of the condition.
引用
收藏
页码:648 / 656
页数:9
相关论文
共 50 条
  • [1] Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibility
    Islander, G
    Örding, H
    Bendixen, D
    Twetman, ER
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2002, 46 (09) : 1144 - 1149
  • [2] MALIGNANT HYPERTHERMIA SUSCEPTIBILITY REVEALED BY THE INVITRO CONTRACTURE TEST
    KLEIN, W
    SPIESSKIEFER, C
    KUTHER, G
    PONGRATZ, D
    LEHMANNHORN, F
    [J]. ANAESTHESIST, 1987, 36 (12): : 685 - 691
  • [3] Between-center variability of results of the in vitro contracture test for malignant hyperthermia susceptibility
    Ording, H
    Islander, G
    Bendixen, D
    Ranklev-Twetman, E
    [J]. ANESTHESIA AND ANALGESIA, 2000, 91 (02): : 452 - 457
  • [4] High-purity ryanodine contracture test for in vitro diagnosis of malignant hyperthermia susceptibility
    Fricker, R
    Musat, J
    Sipos, E
    Gilly, H
    Kress, HG
    [J]. ANESTHESIOLOGY, 1996, 85 (3A) : A977 - A977
  • [5] THE DIAGNOSIS OF MALIGNANT HYPERTHERMIA SUSCEPTIBILITY .1. SIGNIFICANCE OF THE IN-VITRO CONTRACTURE TEST
    MORTIER, W
    BREUCKING, E
    [J]. ANAESTHESIST, 1993, 42 (10): : 675 - 683
  • [6] In vitro skeletal muscle contracture responses to sevoflurane - a potential diagnostic test for malignant hyperthermia susceptibility?
    Hopkins, PM
    Halsall, PJ
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2004, 92 (02) : 311 - 312
  • [7] In vitro contracture test and gene typing in diagnosing malignant hyperthermia
    Rüffert, H
    Olthoff, D
    Deutrich, C
    Thamm, B
    Froster, U
    [J]. ANAESTHESIST, 2000, 49 (02): : 113 - 120
  • [8] The ryanodine contracture test may help diagnose susceptibility to malignant hyperthermia
    Reuter, DA
    Anetseder, M
    Müller, R
    Roewer, N
    Hartung, EJ
    [J]. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2003, 50 (07): : 643 - 648
  • [9] INVITRO CONTRACTURE TESTS FOR SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA
    ROSENBERG, H
    REED, S
    [J]. ANESTHESIA AND ANALGESIA, 1983, 62 (04): : 415 - 420
  • [10] In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein, Thomas
    Schuster, Frank
    Kranke, Peter
    Roewer, Norbert
    Anetseder, Martin
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2011, 28 (04) : 251 - 255